RH
Rhythm Biosciences Limited
RHY.AX · ASX
$0.08 -1.20% (-$0.00)
1M -7.78%
Market Cap $29.4M
P/E Ratio -
Div. Yield -
ROE 209.56%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 8.08x
P/S 344.17x
PEG N/A
Growth
0 /100
Declining Book val. growth 14.77%
Rev. growth 69.79%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 6,162.22%
Op. margin 8,739.15%
Gross margin 5,151.30%
Quality
0 /100
Poor Asset turnover 0.02x
ROA 124.14%
ROIC 150.82%
Debt
69 /100
Low Current ratio 3.61x
Int. coverage -99.70x
Debt/Equity 0.07x
Stability
30 /100
Unstable Profitable years 0
EPS volatility 38.77%
Beta 0.43x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RHY.AX
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
David Atkins
Employees
23
Headquarters
Parkville
Prihajajoči dogodki
24 FEB.
Earnings
Upcoming earnings report